FDA DEVICE FACTS
Sterile Nitrile Powder Free Examination Gloves Tested For Use With Chemotherapy Drugs And Fentanyl Citrate (Blue)
Grand Work Plastic Products Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. In addition these gloves were tested for use with Chemotherapy drugs in accordance with ASTM D6978 standards. Gloves is direct contact and not to be worn for more than 24 hours Chemotherapy Drug Bleomycin Sulfate 15mg/ml (15000 ppm) Busulfan 6mg/ml (6,000 ppm) Carboplatin 10mg/ml (10,000 ppm) Carmustine 3.3 mg/ml (3,300 ppm) Chloroquine 50mg/ml (50,000ppm) Cisplatin lmg/ml (1,000 ppm) Cyclophosphamide 20mg/ml (20,000 ppm) Cyclosporin 100 mg/ml (100,000 ppm) Cytarabine HCL, 100 mg/ml (100,000 ppm) Dacarbazine 10 mg/ml (10,000 ppm) Daunorubicin HCL, 5 mg/ml (5,000 ppm) Docetaxel HCL, 10 mg/ml (10,000 ppm) Doxorubicin HCL, 2 mg/ml (2,000 ppm) Epirubicin HCL, 2 mg/ml (2,000 ppm) Etoposide, 20 mg/ml (20,000 ppm) Fludarabine, 25 mg/ml (25,000 ppm) Fluorouracil, 50mg/ml (50,000ppm) Gemcitabine, 38mg/ml (38,000ppm) Idarubicin HCL, lmg/ml (1,000ppm) Ifosfamide, 50mg/ml (50,000ppm) Irinotecan, 20mg/ml (20,000ppm) Mechlorethamine HCI, lmg/ml (1,000ppm) Melphalan, 5mg/ml (5,000ppm) Methotrexate, 25mg/ml (25,000ppm) Mitomycin C, 0.5mg/ml (500ppm) Mitoxantrone HCL, 2mg/ml (2,000ppm) Oxaliplatin, 5mg/ml (5,000ppm) Paclitaxel, 6mg/ml (6,000ppm) Paraplatin, 10mg/ml (10,000ppm) Retrovir, 10mg/ml (10,000ppm) Rituximab, 1Omg/ml (10,000ppm) Thiotepa, 1Omg/ml (10,000ppm) Topotecan, 1mg/ml (1,000ppm) Trisenox, lmg/ml (1,000ppm) Velcade, 1mg/ml (1,000ppm) Vincristine Sulfate, lmg/ml (1,000ppm) Minimum BDT (Minutes) >240 >240 >240 22.4 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 46.3 >240 >240 >240 >240 * Please note that the following drugs have extremely low permeation times: Carmustine: 22.4 minutes, Thiotepa: 46.3 minutes NG: DO NOT USE WITH CA USTINEWA WARNING: DO NOT USE WITH THIOTEPA Fentanyl Citrate and Concentration Fentanyl Citrate Injection (100 mcg/2ml) Minimum Breakthrough Detection Time in Minutes >240
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。